Eternal Peptides
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Eternal Peptides between 7 May 2025 and 25 Mar 2026. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Eternal Peptides
Retatrutide
Tested 5 Samples
Last test 25 Mar 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Eternal Peptides
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
25 Mar 2026
First
7 May 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 Mar 2026 | View | 10mg | 9.1mg | 10.9mg | +19.6% | 99.70% | EP-2506012-RE10 | White Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 21 May 2025 | View | 10mg | 11.9mg | 10.58mg | -10.8% | 99.33% | 2024-12-20 | White Label / Silver Crimp / Red Caps | Lab D | Finnrick | |
| 21 May 2025 | View | 10mg | 11.9mg | 10.56mg | -11.0% | 99.27% | 2024-12-20 | White Label / Silver Crimp / Red Caps | Lab D | Finnrick | |
| 7 May 2025 | View | 10mg | 11.9mg | 10.3mg | -13.2% | 100.00% | 2024-12-20 | White Label / Silver Crimp / Red Caps | Lab E | Finnrick | |
| 7 May 2025 | View | 10mg | 11.9mg | 10.3mg | -13.2% | 100.00% | 2024-12-20 | White Label / Silver Crimp / Red Caps | Lab E | Finnrick | |